This regulatory approval is the second for VYVGART SC in Europe, which first received approval as an add-on to standard therapy for the treatment of adult patients with generalized myasthenia gravis ...

Commission released the much-anticipated MAHA Report. The report conveys the commission's thinking about what is driving the "increase in childhood chronic disease," in particular, "obesity, diabetes, ...

The 2024 American College of Rheumatology (ACR) annual meeting spotlighted transformative advancements in cell therapies for autoimmune diseases, with chimeric antigen receptor (CAR)-T therapies ...

Luton, Bedfordshire, United Kingdom, June 16, 2025 (GLOBE NEWSWIRE) -- The global mRNA vaccine core enzyme market is witnessing unprecedented growth, driven by heightened demand for rapid vaccine ...

The latest start-up to emerge from the Roivant stable is named Priovant Therapeutics, and has been formed to develop a JAK1/TYK2 inhibitor originated by Pfizer as a treatment for autoimmune diseases.

Three of the 16 patients were started on MMF for reasons other than AIH. AI: Autoimmune; AIH: Autoimmune hepatitis; AST: Aspartate aminotransferase; AZA: Azathioprine; MMF: Mycophenolate mofetil ...

Rheumatoid arthritis (RA) is a type of autoimmune disease in which your body attacks healthy joint tissue. Common symptoms of RA include morning stiffness and joint pain, typically in the same ...

Graves' disease is an autoimmune condition that causes your thyroid to become hyperactive, making it work harder than it needs to. It is one of the most common thyroid problems and the leading ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Astral Ltd Consolidated March 2025 Net Sales at Rs 1,681.40 crore, up 3.46% Y-o-Y May 22 2025 11:18 AM Astral Ltd Standalone March 2025 Net Sales at Rs 1,542.30 crore, up 3.64% Y-o-Y May 21 2025 ...